Johnson & Johnson executive to speak at RBS CEO Lecture Series March 31 @ 6 PM
Alumnus Sheri S. McCoy (MBA ’88), Vice Chairman, Executive Committee, and member of the Office of the Chairman at Johnson & Johnson will be presenting "The Challenge of Innovation in a Dynamic Global Market," in the next installment of the Rutgers Business School (RBS) CEO Lecture Series on Thursday, March 31.
"We are excited to welcome one of our premier alumni back to Rutgers Business School to share her experience and knowledge with us,” said Michael Sarshad, President of the RBS Pharmaceutical Management Club. “Our relationship with Johnson & Johnson has grown stronger throughout the years, and we consider Sheri McCoy an inspiration for all aspiring global business leaders here at Rutgers.”
The hour-long talk and Q & A will be the fourth installment of RBS’s CEO Lecture Series hosted by Interim Dean Glenn Shafer and the Rutgers Business School Board of Advisers.
In the past, the CEO Lecture Series at Rutgers Business School has brought back notable alumni such as Ralph Izzo, CEO of energy giant PSEG who spoke about climate change and its implications for national security and the economy, Thomas A. Renyi, former CEO and Chairman of The Bank of New York Mellon, who spoke about how to manage financial services companies in chaotic times, and Joseph Pieroni, CEO of Daiichi Sankyo, who spoke about how health care reform is changing the biopharma industry.
The deep corporate partnerships and commitment by distinguished alumni like Sheri McCoy maintains RBS’s standing as a premier business school dedicated to solving today’s difficult business challenges.
About Sheri S. McCoy
Sheri S. McCoy is Vice Chairman, Executive Committee, and member of the Office of the Chairman, Johnson & Johnson, with responsibility for the Pharmaceutical and Consumer business segments. She was named to this role in December 2010. Previously, she was worldwide chairman, Pharmaceuticals, a position she assumed in January 2009. Her appointment followed a diverse career in the Corporation’s Consumer and Medical Devices businesses.
Sheri began her Johnson & Johnson career in 1982 as a scientist in the research and development organization supporting the Consumer women’s health business. Advancing through positions of increasing responsibility, she served as head of the consumer R&D organization and later as global president of the Baby and Wound care consumer franchises. In 2005, she became Company Group Chairman for the Ethicon device franchise and a member of the Medical Device & Diagnostics Group Operating Committee, and assumed responsibility for the Group’s businesses in Latin America. Three years later, she was named Chairman of the Surgical Care Group, and became a member of the Johnson & Johnson Executive Committee.
In her most recent position as worldwide chairman of the Pharmaceuticals Group, Sheri led the organization through a period of significant product launches, acquisitions and partnerships, and pipeline advances, while managing through significant loss of patent exclusivity. She is a passionate advocate for diversity of thought, leadership development, employee engagement and customer focus.
Sheri represents the Corporation on the board of PhRMA, the industry trade association, and is a member of the board of the National Quality Forum and of the Institutes of Medicine’s Roundtable on Value & Science-Driven Healthcare. She serves as a board member of FIRST, a non-profit organization created to inspire young people’s interest and participation in science and technology; a member of the Rutgers University President’s Business Leaders Cabinet, and as a board member of Stonehill College.
Sheri holds four U.S. patents. She has a B.S. degree in textile chemistry from the University of Massachusetts, Dartmouth, a master’s degree in chemical engineering from Princeton University, and an MBA from Rutgers University.
By Hannah B. Redmond